Literature DB >> 28192559

Trends in Central Nervous System-Active Polypharmacy Among Older Adults Seen in Outpatient Care in the United States.

Donovan T Maust1, Lauren B Gerlach2, Anastasia Gibson2, Helen C Kales1, Frederic C Blow1, Mark Olfson3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28192559      PMCID： PMC5378654          DOI： 10.1001/jamainternmed.2016.9225

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

2.  Antidepressant use and lifetime history of mental disorders in a community sample: results from the Baltimore Epidemiologic Catchment Area Study.

Authors:  Yoichiro Takayanagi; Adam P Spira; O Joseph Bienvenu; Rebecca S Hock; Michelle C Carras; William W Eaton; Ramin Mojtabai
Journal:  J Clin Psychiatry       Date:  2015-01       Impact factor: 4.384

3.  Population Of US Practicing Psychiatrists Declined, 2003-13, Which May Help Explain Poor Access To Mental Health Care.

Authors:  Tara F Bishop; Joanna K Seirup; Harold Alan Pincus; Joseph S Ross
Journal:  Health Aff (Millwood)       Date:  2016-07-01       Impact factor: 6.301
  3 in total
  13 in total

Review 1.  Update on Medication Use Quality and Safety in Older Adults, 2017.

Authors:  Shelly L Gray; Zachary A Marcum; Kenneth E Schmader; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2018-11-13       Impact factor: 5.562

2.  Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States.

Authors:  Lauren B Gerlach; Mark Olfson; Helen C Kales; Donovan T Maust
Journal:  J Am Geriatr Soc       Date:  2017-05-03       Impact factor: 5.562

3.  Initiation of new psychotropic prescriptions without a psychiatric diagnosis among US adults: Rates, correlates, and national trends from 2006 to 2015.

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Health Serv Res       Date:  2018-10-17       Impact factor: 3.402

4.  Continuing versus New Antidepressant Use in Older Adults: US Prescribing Trends from 2006 to 2015.

Authors:  Taeho Greg Rhee
Journal:  Eur Geriatr Med       Date:  2018-06-14       Impact factor: 1.710

5.  Sources of opioid medication for misuse in older adults: results from a nationally representative survey.

Authors:  Ty S Schepis; Sean Esteban McCabe; Christian J Teter
Journal:  Pain       Date:  2018-08       Impact factor: 7.926

Review 6.  Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

Authors:  Daniel F Kripke
Journal:  F1000Res       Date:  2016-05-19

Review 7.  The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations.

Authors:  Khalaf Kridin; Ralf J Ludwig
Journal:  Front Med (Lausanne)       Date:  2018-08-20

8.  Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study.

Authors:  Samuel W Terman; Carole E Aubert; Chloe E Hill; Donovan T Maust; John P Betjemann; Cynthia M Boyd; James F Burke
Journal:  Epilepsy Behav       Date:  2020-07-03       Impact factor: 2.937

9.  Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US.

Authors:  Donovan T Maust; Julie Strominger; H Myra Kim; Kenneth M Langa; Julie P W Bynum; Chiang-Hua Chang; Helen C Kales; Kara Zivin; Erica Solway; Steven C Marcus
Journal:  JAMA       Date:  2021-03-09       Impact factor: 56.272

10.  Improving admission medication reconciliation with pharmacists or pharmacy technicians in the emergency department: a randomised controlled trial.

Authors:  Joshua M Pevnick; Caroline Nguyen; Cynthia A Jackevicius; Katherine A Palmer; Rita Shane; Galen Cook-Wiens; Andre Rogatko; Mackenzie Bear; Olga Rosen; David Seki; Brian Doyle; Anish Desai; Douglas S Bell
Journal:  BMJ Qual Saf       Date:  2017-10-06       Impact factor: 7.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.